Mizrahi, Romina

Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes

Setiawan, E., Wilson, A. A., Mizrahi, R., Rusjan, P. M., Miler, L., Rajkowska, G., Suridjan, I., Kennedy, J. L., Rekkas, P. V., Houle, S., et al. (2015) · JAMA Psychiatry

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 939

From dopamine to salience to psychosis—Linking biology, pharmacology and phenomenology of psychosis

Kapur, S., Mizrahi, R., & Li, M. (2005) · Schizophrenia Research

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 512

Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review

Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016) · Molecular Psychiatry

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 360

Increased stress-induced dopamine release in psychosis

Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 277

Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [ 18 F]-FEPPA

Mizrahi, R., Rusjan, P. M., Kennedy, J., Pollock, B., Mulsant, B., Suridjan, I., De Luca, V., Wilson, A. A., & Houle, S. (2012) · Journal of Cerebral Blood Flow & Metabolism

Neuroinflammation and Neurodegeneration MechanismsMedical Imaging Techniques and Applications

Cited by 155

Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis

ENIGMA Clinical High Risk for Psychosis Working Group, Jalbrzikowski, M., Hayes, R. A., Wood, S. J., Nordholm, D., Zhou, J. H., Fusar-Poli, P., Uhlhaas, P. J., Takahashi, T., Sugranyes, G., et al. (2021) · JAMA Psychiatry

Schizophrenia research and treatmentPsychopathy, Forensic Psychiatry, Sexual Offending

Cited by 137

In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA

Suridjan, I., Pollock, B. G., Verhoeff, N. P. L. G., Voineskos, A. N., Chow, T., Rusjan, P. M., Lobaugh, N. J., Houle, S., Mulsant, B. H., & Mizrahi, R. (2015) · Molecular Psychiatry

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 132

Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use

Mizrahi, R., Kenk, M., Suridjan, I., Boileau, I., George, T. P., McKenzie, K., Wilson, A. A., Houle, S., & Rusjan, P. (2014) · Neuropsychopharmacology

Schizophrenia research and treatmentCannabis and Cannabinoid Research

Cited by 101

Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease

Koshimori, Y., Ko, J.-H., Mizrahi, R., Rusjan, P., Mabrouk, R., Jacobs, M. F., Christopher, L., Hamani, C., Lang, A. E., Wilson, A. A., et al. (2015) · PLOS ONE

Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments

Cited by 100

Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment

Knezevic, D., & Mizrahi, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 97

Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.

Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., et al. (2016) · Biological Psychiatry

Cannabis and Cannabinoid ResearchForensic Toxicology and Drug Analysis

Cited by 82

Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA

Suridjan, I., Rusjan, P. M., Voineskos, A. N., Selvanathan, T., Setiawan, E., Strafella, A. P., Wilson, A. A., Meyer, J. H., Houle, S., & Mizrahi, R. (2014) · NeuroImage

Neuroinflammation and Neurodegeneration MechanismsMedical Imaging Techniques and Applications

Cited by 71

Impaired prefrontal cortical dopamine release in schizophrenia during a cognitive task: A [11C]FLB 457 positron emission tomography study

Rao, N., Northoff, G., Tagore, A., Rusjan, P., Kenk, M., Wilson, A., Houle, S., Strafella, A., Remington, G., & Mizrahi, R. (2019) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 67

Country-level gender inequality is associated with structural differences in the brains of women and men

Zugman, A., Alliende, L. M., Medel, V., Bethlehem, R. A. I., Seidlitz, J., Ringlein, G., Arango, C., Arnatkevičiūtė, A., Asmal, L., Bellgrove, M., et al. (2023) · Proceedings of the National Academy of Sciences

Sex and Gender in HealthcareGender, Health, and Social Inequality

Cited by 65

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task

Suridjan, I., Rusjan, P., Addington, J., Wilson, A. A., Houle, S., & Mizrahi, R. (2013) · Journal of Psychiatry and Neuroscience

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 38

Nigral stress-induced dopamine release in clinical high risk and antipsychotic-naïve schizophrenia

Tseng, H.-H., Watts, J. J., Kiang, M., Suridjan, I., Wilson, A. A., Houle, S., Rusjan, P. M., & Mizrahi, R. (2018) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 31

Corticotropin-releasing hormone and dopamine release in healthy individuals

Payer, D., Williams, B., Mansouri, E., Stevanovski, S., Nakajima, S., Le Foll, B., Kish, S., Houle, S., Mizrahi, R., George, S. R., et al. (2017) · Psychoneuroendocrinology

Stress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

Cited by 26

Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: A [11C]FLB457 positron emission tomography study

Tagore, A., Schifani, C., Rao, N., Tseng, H.-H., Zakzanis, K. K., Rusjan, P. M., Houle, S., & Mizrahi, R. (2019) · European Neuropsychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 3